After several notable moves to grow the reach of its biomanufacturing platform in recent months, Antheia is linking arms with ...

Eli Lilly and Company has announced plans to invest $6.5bn in an active pharmaceutical ingredients (API) manufacturing facility at Generation Park in Houston, in the US state of Texas. The new ...

Read more about HRV Pharma and MetroChem Forge Strategic CDMO Alliance to Fast-Track High-Value NCE-1 API Development on Devdiscourse ...

Eli Lilly and Company (Lilly) plans to construct an active pharmaceutical ingredient (API) manufacturing facility, totaling around 1 million square feet, in Harris County, Texas. According to news ...

(MENAFN- GlobeNewsWire - Nasdaq) The Europe API market is driven by increasing demand for generics and specialty medicines due to patent expirations and cost-containment policies. The rise in ...

Technological innovations throughout the past several decades have transformed the pharmaceutical manufacturing process from traditional batch production to ...

ALBANY, N.Y., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Curia Global, Inc. (Curia), a leading global research, development and manufacturing organization, today announced the completion of a $4 million ...

AstraZeneca has commenced construction of its $4.5bn active pharmaceutical ingredient (API) manufacturing facility in Virginia. The site, which is located near Charlottesville, will produce APIs for ...

Since scoring approval two years ago for its next-generation diabetes treatment Mounjaro (tirzepatide), Eli Lilly has been playing catch up with market leader Novo Nordisk. On Friday, the Indianapolis ...

Mr. Vaibhav Shah, Managing Director, API Metrology India handing over the Authorized Reseller Partner Certificate to Mr. Ajoy Masand, Vice President - Sales, Shree Rapid Technologies SRT partnered ...